As of September 30, 2025, Corvus had cash, cash equivalents and marketable securities of $65.7 million as compared to $52.0 million as of December 31, 2024. Consistent with last quarter, Corvus ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...

Fifteenth Court of Appeals Justice Scott Field said getting the word out about the new Texas Business Courts, which were ...

Residents of St George’s will get a crash course on how to plan for development within the Olde Towne. The Department of ...

Canada is reportedly preparing to reject visa applications from India and Bangladesh amid growing fraud concerns.